BROWSE

Related Scientist

kim,homin's photo.

kim,homin
단백질커뮤니케이션그룹
more info

ITEM VIEW & DOWNLOAD

Structure-based glycoengineering of interferon lambda 4 enhances its productivity and anti-viral potency

DC Field Value Language
dc.contributor.authorChung J.-H.-
dc.contributor.authorHong S.-H.-
dc.contributor.authorSeo N.-
dc.contributor.authorKim T.-S.-
dc.contributor.authorAn H.J.-
dc.contributor.authorLee P.-
dc.contributor.authorEui Cheol, Shin-
dc.contributor.authorHo Min Kim-
dc.date.available2019-10-11T08:05:48Z-
dc.date.created2019-09-24-
dc.date.issued2020-01-
dc.identifier.issn1043-4666-
dc.identifier.urihttps://pr.ibs.re.kr/handle/8788114/6255-
dc.description.abstract© 2019 Elsevier LtdInterferon lambda 4 (IFNλ4) has been recently known and studied for its role in hepatitis C virus (HCV) infection, but its clinical potential is significantly hampered due to its poor expression in vitro. Our study reports the successful production of IFNλ4 from a mammalian cell line through a glycoengineering and structure-based approach. We introduced de novo N-glycosylation of IFNλ4, guided by structural analysis, and produced IFNλ4 variants in Expi293F that displayed improved expression and potency. To preserve the structure and functionality of IFNλ4, the model structure of the IFNλ4 signaling complex was analyzed and the N-glycosylation candidate sites were selected. The receptor binding activity of engineered IFNλ4 variants and their receptor-mediated signaling pathway were similar to the E. coli version of IFNλ4 (eIFNλ4), while the antiviral activity and induction levels of interferon-stimulated gene (ISG) were all more robust in our variants. Our engineered IFNλ4 variants may be further developed for clinical applications and utilized in basic research to decipher the immunological roles of IFNλ4-
dc.language영어-
dc.publisherACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD-
dc.titleStructure-based glycoengineering of interferon lambda 4 enhances its productivity and anti-viral potency-
dc.typeArticle-
dc.type.rimsART-
dc.identifier.wosid000501391800028-
dc.identifier.scopusid2-s2.0-85071520627-
dc.identifier.rimsid69802-
dc.contributor.affiliatedAuthorHo Min Kim-
dc.identifier.doi10.1016/j.cyto.2019.154833-
dc.identifier.bibliographicCitationCYTOKINE, v.125, pp.154833-
dc.relation.isPartOfCYTOKINE-
dc.citation.titleCYTOKINE-
dc.citation.volume125-
dc.citation.startPage154833-
dc.description.journalClass1-
dc.description.journalClass1-
dc.description.isOpenAccessN-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.relation.journalWebOfScienceCategoryBiochemistry & Molecular Biology-
dc.relation.journalWebOfScienceCategoryCell Biology-
dc.relation.journalWebOfScienceCategoryImmunology-
dc.subject.keywordPlusIFN-
dc.subject.keywordPlusGLYCOSYLATION-
dc.subject.keywordPlusRECEPTOR-
dc.subject.keywordPlusPROTEINS-
dc.subject.keywordPlusCOMPLEX-
dc.subject.keywordPlusALPHA-
dc.subject.keywordPlusHCV-
dc.subject.keywordPlusMECHANISMS-
dc.subject.keywordPlusCLEARANCE-
dc.subject.keywordPlusSECRETION-
dc.subject.keywordAuthorIFN lambda 4-
dc.subject.keywordAuthorGlycoengineering-
dc.subject.keywordAuthorHomology modeling-
dc.subject.keywordAuthorType III interferon signaling-
dc.subject.keywordAuthorAnti-viral activity-
Appears in Collections:
Pioneer Research Center for Biomolecular and Cellular Structure(바이오분자 및 세포구조 연구단) > Protein Communication Group(단백질 커뮤니케이션 그룹) > 1. Journal Papers (저널논문)
Files in This Item:
1-s2.0-S1043466619302625-main.pdfDownload

qrcode

  • facebook

    twitter

  • Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse